Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Graves' Orbitopathy
NCT05049603Phase 3Not yet recruiting
- Sponsor
- University of Pisa
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in Graves Orbitopathy (GO), sponsored by University of Pisa. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on NCT05049603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05049603.